Evonik and Ashland.- Notable Market Players in Bioresorbable Medical Material Market
Bioresorbable Medical Material tests are performed with an aim to analyze functioning of kidneys. These tests can offer comprehensive information about level of chronic kidney disease and risk of renal failure. Furthermore, higher levels of creatinine in the blood are attributed to kidney obstruction, dehydration, increased consumption of proteins, and excessive consumption of medications.
Market leaders operating in the market have undertaken various organic growth strategies in the Bioresorbable Medical Material Market. The Bioresorbable Medical Material market majorly consists of the players such as Evonik, Foster Corporation,Poly-Med Incorporated,Zeus Industrial Products, Inc., Ashland, Durect Corporation,Groupe PCAS,DSM, Corbion Putnam Plastics among others. Several organic approaches, such as product launches, and expansion/relocation in the Bioresorbable Medical Material Market, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.
Below is the list of the growth strategies done by the players operating in the Bioresorbable Medical Material market:
|
Year |
News |
|
March-2020 |
Zeus Industrial Products, Inc., a leading polymer solutions provider and material science innovator, has expanded its StreamLiner family of thin, extruded PTFE catheter liners. Using a proprietary process, Zeus can now extrude liners over-the-wire (OTW) in sizes comparable to film cast tubing, but with greater strength. |
|
Oct-2019 |
Evonik, a global leader in biomaterials, today announced the commercial launch of the world’s first bioresorbable portfolio of PLA-PEG copolymers for use in implantable medical device applications. The innovative portfolio expands Evonik’s ability to help medical device customers enhance the safety, biocompatibility and performance of their implantable products, and further strengthens the Company’s growth engine Health & Care. |
|
July-2018 |
Foster Corporation, a leader in polymer material solutions for the medical and pharmaceutical markets inaugurated its a new state-of-the-art manufacturing facility that is adjacent to its headquarters in Putnam, CT. This new expansion comes only a few years after Foster opened a new pharmaceutical building for its “Delivery Science” business. |
|
March-2018 |
Poly-Med, Inc., the leader in bioresorbable solutions, introduced Poly-Med 3D Printing a vertically integrated design and custom manufacturing advantage that produces specialized materials, with innovative design supported by, and in-house fused filament printing services for, the medical device industry. |
